Roche and PTC Therapeutics' Evrysdi for spinal muscular atrophy (SMA) has been approved by the FDA for younger children with the rare disease, extending its use to include infants less than two months ...

Roche is hoping to undercut hugely expensive rivals after the FDA approved its oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam). Evrysdi is the third treatment approved for SMA, an ...

A five-year-old boy who received the world's most expensive drug as a baby has made "incredible progress" and can walk independently, his mother said. Edward, from Colchester, has spinal muscular ...

Edward was one of the first children in England to be given the gene therapy Zolgensma through the NHS A five-year-old boy who received the world's most expensive drug as a baby has made "incredible ...

Chart does not reflect overnight price.

Patients with SMA, which has no cure, typically achieve a better quality of life through physical therapy, posture management, and, among other things, nutritional support. 4 Providing individualized ...

Across the ancient world, from the rocky deserts of the American West all the way to the shores of the Mediterranean, enigmatic parallels between ancient myths and archaeological sites are emerging.

SMA-20 Crossed Above SMA-50 Stocks- 20 day moving avergae above 50 day moving average: The primary application of Simple Moving Average is for analyzing stock trends Multiply the power of your ...